Authors:
Schiller, JH
Adak, S
Feins, RH
Keller, SM
Fry, WA
Livingston, RB
Hammond, MEM
Wolf, B
Sabatini, L
Jett, J
Kohman, L
Johnson, DH
Citation: Jh. Schiller et al., Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A laboratory ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy, J CL ONCOL, 19(2), 2001, pp. 448-457
Authors:
Daly, JM
Fry, WA
Little, AG
Winchester, DP
McKee, RF
Stewart, AK
Fremgen, AM
Citation: Jm. Daly et al., Esophageal cancer: Results of an American College of Surgeons patient careevaluation study, J AM COLL S, 190(5), 2000, pp. 562-572
Authors:
Liptay, MJ
Masters, GA
Winchester, DJ
Edelman, BL
Garrido, BJ
Hirschtritt, TR
Perlman, RM
Fry, WA
Citation: Mj. Liptay et al., Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer, ANN THORAC, 70(2), 2000, pp. 384-389
Citation: Wa. Fry, Chest wall implantation of a mediastinal liposarcoma after thoracoscopy - Invited commentary, ANN THORAC, 69(5), 2000, pp. 1581-1581
Citation: Sr. Hazelrigg et al., The treatment of malignant endobronchial obstruction with laser ablation -Discussion, SURGERY, 126(4), 1999, pp. 733-735
Citation: Wa. Fry et al., Ten-year survey of lung cancer treatment and survival in hospitals in the United States - A National Cancer Data Base report, CANCER, 86(9), 1999, pp. 1867-1876
Citation: Wa. Fry, Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer - Invited commentary, ANN THORAC, 66(6), 1998, pp. 1914-1914